- Release Date: 10/07/23 09:17
- Summary: NTI Receives HREC Approval for Rett Syndrome Clinical Trial
- Price Sensitive: Yes
- Download Document 213.2KB
- Forums
- ASX - By Stock
- NTI
- Ann: NTI Receives HREC Approval for Rett Syndrome Clinical Trial
Ann: NTI Receives HREC Approval for Rett Syndrome Clinical Trial
-
- There are more pages in this discussion • 8 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add NTI (ASX) to my watchlist
|
|||||
Last
6.1¢ |
Change
0.003(5.17%) |
Mkt cap ! $62.06M |
Open | High | Low | Value | Volume |
5.9¢ | 6.3¢ | 5.8¢ | $45.38K | 746.0K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 40246 | 6.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
6.1¢ | 13319 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 40246 | 0.060 |
2 | 111000 | 0.059 |
1 | 973610 | 0.058 |
3 | 186931 | 0.057 |
2 | 204000 | 0.056 |
Price($) | Vol. | No. |
---|---|---|
0.061 | 13319 | 1 |
0.062 | 30000 | 1 |
0.063 | 81753 | 2 |
0.064 | 237283 | 2 |
0.065 | 324000 | 4 |
Last trade - 15.59pm 20/06/2024 (20 minute delay) ? |
Featured News
NTI (ASX) Chart |
The Watchlist
MTL
MANTLE MINERALS LIMITED
Nick Poll, Executive Chairman
Nick Poll
Executive Chairman
Previous Video
Next Video
SPONSORED BY The Market Online